Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1975 Feb;30(1):9–18. doi: 10.1136/thx.30.1.9

Comparative effects of beta adrenergic blocking drugs.

E Sowton, D S Das Gupta, I Baker
PMCID: PMC470238  PMID: 235803

Abstract

Although many different beta blockers are now in clinical use, there is very little information concerning their relative efficacy, and it is still not clear what clinical importance should be attached to properties such as positive inotropic stimulation (intrinsic sympathomimetic activity or ISA) and membrane stabilizing action ("local anaesthetic effect" or "quinidine-like effect"). In this report we compare the ability of patients with angina to exercise on a bicycle ergometer while receiving a series of commonly used beta blockers, and attempt to determine the importance of ISA. The investigation is in four parts with the drugs given orally or intravenously: statistical analysis of the results was carried out using standard methods, both parametric and non-parametric (Friedmann analysis of variance, Wilcoxon matched pairs signed ranks test) by two independent statisticians. The relevant properties of drugs included in this paper are summarized in Table I. Laboratory reports using many different animal preparations may differ from this assessment under specific conditions, and the Table is intended only as a guide to the generally accepted properties of these drugs when used clinically. Results for sotalol are included for reference in the first part of this paper but the drug was withdrawn from clinical use and was not studied further.

Full text

PDF
9

Images in this article

10Image
on p.10

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balcon R., Maloy W. C., Sowton E. Clinical use of atrial pacing test in angina pectoris. Br Med J. 1968 Jul 13;3(5610):91–92. doi: 10.1136/bmj.3.5610.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barrett A. M., Carter J. Comparative chronotropic activity of beta-adrenoceptive antagonists. Br J Pharmacol. 1970 Nov;40(3):373–381. doi: 10.1111/j.1476-5381.1970.tb10619.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Coltart D. J. Comparison of effects of propranolol and practolol on exercise tolerance in angina pectoris. Br Heart J. 1971 Jan;33(1):62–64. doi: 10.1136/hrt.33.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Doyle A. E., Morgan T. O., Louis W. J., Dawborn J. K., Anavekar S. N. The hypotensive action of LB 46. Indian Heart J. 1972 Jun;24(Suppl):231–235. [PubMed] [Google Scholar]
  5. Doyle A. E., Morgan T. O., Louis W. J., Dawborn J. K., Anavekar S. N. The hypotensive action of LB 46. Indian Heart J. 1972 Jun;24(Suppl):231–235. [PubMed] [Google Scholar]
  6. Duner H. The effect of LB 46 on the blood pressure in essential hypertension. Indian Heart J. 1972 Jun;24(Suppl):236–237. [PubMed] [Google Scholar]
  7. Fitzgerald J. D. A new test of the degree of adrenergic beta receptor blockade. Int Z Klin Pharmakol Ther Toxikol. 1970 Dec;4(1):125–130. [PubMed] [Google Scholar]
  8. Gibson D. G. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man. Drugs. 1974;7(1):8–38. doi: 10.2165/00003495-197407010-00002. [DOI] [PubMed] [Google Scholar]
  9. Gillam P. M., Prichard B. N. Propranolol in the therapy of angina pectoris. Am J Cardiol. 1966 Sep;18(3):366–369. doi: 10.1016/0002-9149(66)90055-5. [DOI] [PubMed] [Google Scholar]
  10. Grandjean T., Rivier J. L. Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba. Br Heart J. 1968 Jan;30(1):50–59. doi: 10.1136/hrt.30.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Heterington D. J., Comerford M. B., Nyberg G., Besterman E. M. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris. Br Heart J. 1973 Mar;35(3):320–333. doi: 10.1136/hrt.35.3.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hill R. C., Turner P. Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man. Br J Pharmacol. 1969 Jun;36(2):368–372. doi: 10.1111/j.1476-5381.1969.tb09511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kerber R. E., Goldman R. H., Alderman E. L., Harrison D. C. Circulatory responses to beta adrenergic blockade with alprenolol. Studies in patients with chronic heart disease. Am J Cardiol. 1972 Jan;29(1):26–32. doi: 10.1016/0002-9149(72)90411-0. [DOI] [PubMed] [Google Scholar]
  14. Sealey B. J., Liljedal J., Nyberg G., Ablad B. Acute effects of oral alprenolol on exercise tolerance in patients with angina pectoris. A dose-response study. Br Heart J. 1971 Jul;33(4):481–488. doi: 10.1136/hrt.33.4.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sowton E., Smithen C. Double-blind three-dose trial of oral alprenolol in angina pectoris. Br Heart J. 1971 Jul;33(4):601–606. doi: 10.1136/hrt.33.4.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Thadani U., Sharma B., Meeran M. K., Majid P. A., Whitaker W., Taylor S. H. Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J. 1973 Jan 20;1(5846):138–142. doi: 10.1136/bmj.1.5846.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wilson D. F., Watson O. F., Peel J. S., Langley R. B., Turner A. S. Some haemodynamic effects of trasicor (Ciba 39,089-Ba). N Z Med J. 1968 Sep;68(436):145–149. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES